Ophthalmology

Top Story

Ivantis cleared to begin trial of Hydrus in advanced glaucoma

April 25, 2017

The FDA has cleared Ivantis to begin a second investigational device exemption clinical trial for its Hydrus microstent, according to a company press release.

The clearance will allow the company to study the microstent in patients with advanced glaucoma who are undergoing standalone glaucoma surgery without combined cataract surgery.

In the Journals

Study compares outcomes of pediatric primary and secondary IOL implantation

April 24, 2017
Pediatric patients who underwent secondary IOL implantation for pediatric cataract experienced generally worse best corrected visual acuity and a higher risk for…

Shire studies SHP640 for infectious conjunctivitis

April 24, 2017
The first U.S. patient has been enrolled in a phase 3 clinical trial for Shire’s SHP640, a combination broad-spectrum antiseptic and corticosteroid being evaluated…
In the Journals

Study investigates role of PVD and VMA in progression of AMD

April 24, 2017
A higher incidence of vitreoretinal interface abnormalities was found in patients with exudative age-related macular degeneration as compared with patients with dry AMD…

Drug candidate for DME treatment to begin toxicology studies

April 24, 2017
THR-149, a plasma kallikrein inhibitor for the potential treatment of diabetic macular edema, has reached a milestone in its development and will start pivotal…
More News Headlines »
Clinical Science

Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular Degeneration

Ophthalmic Surgery, Lasers and Imaging Retina, April 2017, Volume 48 Issue 4
The aim of this study was to identify the rate of early visual acuity poor responders in patients with neovascular…
More »
CME

Inflamed and Untamed: Managing the Progression of Diabetic Eye Disease

This activity is supported by an educational grant from Allergan, Inc.

Diabetic retinopathy (DR) is a major cause of blindness, with an estimated 4.2 million people over the age of 40…
More »
Featured
Video
Meeting News

VIDEO: HR experts tackle hot topics from immigration to Generation Z

March 1, 2017
More »
Advertisement
Advertisement